SPALLUTO, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 3.275
AS - Asia 1.979
EU - Europa 932
SA - Sud America 277
AF - Africa 30
OC - Oceania 3
Totale 6.496
Nazione #
US - Stati Uniti d'America 3.205
SG - Singapore 668
CN - Cina 587
BR - Brasile 203
VN - Vietnam 199
UA - Ucraina 187
DE - Germania 185
HK - Hong Kong 161
TR - Turchia 158
GB - Regno Unito 137
SE - Svezia 76
FI - Finlandia 73
FR - Francia 66
IN - India 57
IT - Italia 56
JP - Giappone 47
RU - Federazione Russa 40
MX - Messico 32
CA - Canada 31
AR - Argentina 29
PL - Polonia 27
ES - Italia 20
BD - Bangladesh 19
ZA - Sudafrica 18
AT - Austria 15
IQ - Iraq 15
NL - Olanda 14
EC - Ecuador 11
LT - Lituania 8
SA - Arabia Saudita 8
BE - Belgio 7
CO - Colombia 7
VE - Venezuela 7
ID - Indonesia 6
JO - Giordania 6
MA - Marocco 6
PK - Pakistan 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
IR - Iran 3
MY - Malesia 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 6.496
Città #
Singapore 433
Ashburn 300
Woodbridge 272
Chandler 251
Houston 228
Fairfield 204
Jacksonville 198
Beijing 190
San Jose 184
Ann Arbor 164
Hong Kong 161
Santa Clara 140
Nanjing 87
Wilmington 85
Izmir 76
Dallas 73
Ho Chi Minh City 67
Seattle 66
Los Angeles 57
Cambridge 53
Munich 49
Hanoi 47
Princeton 46
New York 42
Tokyo 37
Boardman 35
Dearborn 35
Lauterbourg 27
Shanghai 26
São Paulo 23
London 22
Shenyang 22
Orem 21
Turku 21
Nanchang 19
Warsaw 19
Milan 18
Hefei 17
Mexico City 17
San Diego 17
Brooklyn 16
Frankfurt am Main 16
Tianjin 16
Addison 14
Buffalo 14
Chennai 14
Falkenstein 14
Helsinki 14
San Mateo 14
Vienna 14
Changsha 13
Jiaxing 11
San Francisco 11
Da Nang 10
Hebei 10
Toronto 10
Atlanta 9
Jinan 9
Johannesburg 9
Moscow 9
Rio de Janeiro 9
Zhengzhou 9
Bremen 8
Chicago 8
Falls Church 8
Kunming 8
Mumbai 8
Norwalk 8
Phoenix 8
Poplar 8
Amsterdam 7
Boston 7
Manchester 7
Ningbo 7
Ottawa 7
Taizhou 7
Amman 6
Brussels 6
Council Bluffs 6
Haiphong 6
Montreal 6
Philadelphia 6
Denver 5
Ferrara 5
Verona 5
Ankara 4
Baghdad 4
Biên Hòa 4
Bắc Ninh 4
Charlotte 4
City of London 4
Delhi 4
Dublin 4
Hải Dương 4
Istanbul 4
Olomouc 4
Porto Alegre 4
Pune 4
Queens 4
Stockholm 4
Totale 4.331
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 320
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 265
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 250
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 241
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 233
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 233
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 227
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 214
Mastering β-Keto Esters 211
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 210
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 209
A new synthetic approach to indazole synthesis 206
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 203
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 197
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 195
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 190
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 186
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 175
New potent and selective human adenosine A3 receptor antagonists 174
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 173
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 173
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 139
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 132
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 131
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 125
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 123
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 118
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 117
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 114
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 114
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 114
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 112
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 109
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 106
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 102
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 100
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 97
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 92
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 83
Totale 6.513
Categoria #
all - tutte 26.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021131 0 0 0 0 0 0 0 0 0 40 69 22
2021/2022395 9 42 19 27 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20262.414 288 91 220 380 397 188 229 108 259 254 0 0
Totale 6.513